Skip to main content
Clinical Trials/NL-OMON47026
NL-OMON47026
Completed
N/A

Imaging the neurodevelopmental consequences of intrauterine exposure to Antipsychotics and Lithium - The Image_AL study

Overview

Phase
N/A
Intervention
Not specified
Conditions
Concequences of intrauterine exposure to lithium or antipyschotics
Sponsor
Erasmus MC, Universitair Medisch Centrum Rotterdam
Enrollment
441
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • Children born between 2003\-2012:
  • \- Children of mothers treated with antipsychotics or lithium during pregnancy
  • \- Children of mothers diagnosed with one of the following disorders during pregnancy: bipolar disorder, schizophrenia, schizoaffective disorder, psychosis NOS or borderline personality disorder. \- Children of mothers who developed postpartum psychosis (PP) after childbirth.
  • \- Children of women who developed schizophrenia within five years postpartum.

Exclusion Criteria

  • Children will be excluded if they were exposed to both lithium and antipsychotics in utero, or if their mother used recreational drugs or antiepileptic medication during pregnancy.

Outcomes

Primary Outcomes

Not specified

Similar Trials